Smith DC - Search Results

1

Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.

Herman JM, Smith DC, Montie J, Hayman JA, Sullivan MA, Kent E, Griffith KA, Esper P, Sandler HM. Herman JM, et al. Among authors: smith dc. Urology. 2004 Jul;64(1):69-73. doi: 10.1016/j.urology.2004.02.024. Urology. 2004. PMID: 15245938 Clinical Trial.

2

A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer.

Pienta KJ, Redman BG, Bandekar R, Strawderman M, Cease K, Esper PS, Naik H, Smith DC. Pienta KJ, et al. Among authors: smith dc. Urology. 1997 Sep;50(3):401-6; discussion 406-7. doi: 10.1016/S0090-4295(97)00228-8. Urology. 1997. PMID: 9301705 Clinical Trial.

3

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer.

Smith DC, Redman BG, Flaherty LE, Li L, Strawderman M, Pienta KJ. Smith DC, et al. Urology. 1998 Aug;52(2):257-60. doi: 10.1016/s0090-4295(98)00173-3. Urology. 1998. PMID: 9697791 Clinical Trial.

4

Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer.

Esper P, Hampton JN, Smith DC, Pienta KJ. Esper P, et al. Among authors: smith dc. Oncol Nurs Forum. 1999 Jan-Feb;26(1):107-12. Oncol Nurs Forum. 1999. PMID: 9921573

5

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

Sanda MG, Smith DC, Charles LG, Hwang C, Pienta KJ, Schlom J, Milenic D, Panicali D, Montie JE. Sanda MG, et al. Among authors: smith dc. Urology. 1999 Feb;53(2):260-6. doi: 10.1016/s0090-4295(98)00539-1. Urology. 1999. PMID: 9933036

6

Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.

Smith DC, Esper P, Strawderman M, Redman B, Pienta KJ. Smith DC, et al. J Clin Oncol. 1999 Jun;17(6):1664-71. doi: 10.1200/JCO.1999.17.6.1664. J Clin Oncol. 1999. PMID: 10561202 Clinical Trial.

7

A new concept in cancer care: the supportive care program.

Esper P, Hampton JN, Finn J, Smith DC, Regiani S, Pienta KJ. Esper P, et al. Among authors: smith dc. Am J Hosp Palliat Care. 1999 Nov-Dec;16(6):713-22. doi: 10.1177/104990919901600608. Am J Hosp Palliat Care. 1999. PMID: 11094908 Free article.

8

Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens.

Mucci NR, Rubin MA, Strawderman MS, Montie JE, Smith DC, Pienta KJ. Mucci NR, et al. Among authors: smith dc. J Natl Cancer Inst. 2000 Dec 6;92(23):1941-2. doi: 10.1093/jnci/92.23.1941. J Natl Cancer Inst. 2000. PMID: 11106686 No abstract available.

9

Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.

Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, Jones J, Balcerzak SP, Crawford ED, Grossman HB. Hussain MH, et al. Among authors: smith dc. J Urol. 2001 Jan;165(1):56-60; discussion 60-1. doi: 10.1097/00005392-200101000-00014. J Urol. 2001. PMID: 11125363 Clinical Trial.

10

Pelvic recurrences post cystectomy: current treatment strategies.

Schuster TG, Smith DC, Montie JE. Schuster TG, et al. Among authors: smith dc. Semin Urol Oncol. 2001 Feb;19(1):45-50. Semin Urol Oncol. 2001. PMID: 11246733 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,042 results

Search Page

Filters